Archived Insight | November 5, 2020

HR, Employee Benefits and the 2020 Election

This November 5, 2020 webinar featured insights from Segal compliance experts and guest presenter Jim Klein, President of the American Benefits Council.

The webinar addressed what this election could mean for vital employee benefit and HR issues, including the future of the ACA, and other healthcare topics, plus evolving retirement and financial security programs.

We also shared the results of an election night survey that asked voters question about key employee benefit preferences aimed at helping plan sponsors further understand the most valued programs.

employee benefits 2020 election

 

Get the slides from this webinar

Don’t have time to watch a video right now? No worries. Here is a copy of the slides.

Download the PDF slides

Do you have questions about the topics in this webinar?

We have answers.

Ask you question

See more insights

Asian Female Pharmacist Uses Computer To Check Inventory For A Drug

Designing and Negotiating Affordable Pharmacy Benefits

Learn how health plan sponsors can improve pharmacy benefit value through PBM contracting, formulary management and clinical oversight.

Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Corporate, Pharmaceutical, Healthcare Cost Management

Read Full Insight

Focused Business Woman Working On Laptop Computer Reading

Many Retirement Plans Must Be Amended by December 31, 2026

Learn which retirement plans must be amended by December 31, 2026 and how SECURE Act discretionary and required amendments differ.

Retirement, Compliance, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Corporate

Read Full Insight

Man Self Injecting GLP 1 Weight Loss Medication Pen At Home

GLP-1s Have Disrupted the Market for Other Diabetes Drugs

Segal’s SHAPE data shows how rising GLP-1 use coincided with declines in insulin, Metformin and DPP-4 inhibitor use.

Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Corporate, Pharmaceutical

Read Full Insight

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.